AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo's (OTCPK:DSKYF) drug Enhertu has been approved by the FDA for the treatment of certain breast cancer patients. Enhertu was approved for the treatment of ...

As hair thinning and skin aging continue to be prevalent concerns worldwide, VCare's latest GFC treatment has emerged as a ...

A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and ...

Ncardia, a leading human induced pluripotent stem cell (hiPSC) technology company, today announced the launch of Ncyte® Heart ...

Madison Keys attributed her breakthrough victory in securing her first Grand Slam title to extensive therapy, which she said ...

Tennis Focus, Hot Topics Madison Keys spoke about her journey over the last year after claiming a maiden Grand Slam title.

Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.

This week, Bruno Mars gets sexy with Sexyy, Travis Scott delivers his stadium-sized new single and Central Cee proves that ...

Revolutionary medical treatments offer new hope for chronic pain sufferers through advanced technology, targeted medications ...

Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

The FDA has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta.